Herbert L. Bonkovsky

32.7k total citations · 3 hit papers
369 papers, 20.0k citations indexed

About

Herbert L. Bonkovsky is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Herbert L. Bonkovsky has authored 369 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Molecular Biology, 108 papers in Hepatology and 105 papers in Epidemiology. Recurrent topics in Herbert L. Bonkovsky's work include Heme Oxygenase-1 and Carbon Monoxide (127 papers), Porphyrin Metabolism and Disorders (107 papers) and Liver Disease Diagnosis and Treatment (94 papers). Herbert L. Bonkovsky is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (127 papers), Porphyrin Metabolism and Disorders (107 papers) and Liver Disease Diagnosis and Treatment (94 papers). Herbert L. Bonkovsky collaborates with scholars based in United States, Canada and Germany. Herbert L. Bonkovsky's co-authors include Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Barbara F. Banner, Timothy R. Morgan, Jules L. Dienstag, Anna S. Lok, Richard W. Lambrecht, Marc G. Ghany and Naga Chalasani and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Herbert L. Bonkovsky

355 papers receiving 19.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

2014 641 citations Naga Chalasani, Herbert L. Bonkovsky et al. The American Journal of Gastroenterology profile →
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

2008 638 citations Naga Chalasani, Robert J. Fontana et al. Gastroenterology profile →
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

2014 292 citations Victor J. Navarro, Huiman X. Barnhart et al. Hepatology profile →

Peers

Herbert L. Bonkovsky

EPIDE

HEPAT

PHARM

PPCH

Neil Kaplowitz United States

Christopher P. Day United Kingdom

Claude Degott France

Christian P. Strassburg Germany

Ann K. Daly United Kingdom

Claudio Tiribelli Italy

Einar S. Björnsson Iceland

Guruprasad P. Aithal United Kingdom

Hanns–Ulrich Marschall Sweden

Dominique Larrey France

Neil Kaplowitz United States

Herbert L. Bonkovsky

9.7k ×1.3

EPIDE

7.9k ×1.1

HEPAT

8.4k ×1.3

9.2k ×2.6

PHARM

1.5k ×0.7

PPCH

Citations per year, relative to Herbert L. Bonkovsky Herbert L. Bonkovsky (= 1×) peers Neil Kaplowitz

Countries citing papers authored by Herbert L. Bonkovsky

Since Specialization

Citations

This map shows the geographic impact of Herbert L. Bonkovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert L. Bonkovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert L. Bonkovsky more than expected).

Fields of papers citing papers by Herbert L. Bonkovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert L. Bonkovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert L. Bonkovsky. The network helps show where Herbert L. Bonkovsky may publish in the future.

Co-authorship network of co-authors of Herbert L. Bonkovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert L. Bonkovsky. A scholar is included among the top collaborators of Herbert L. Bonkovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert L. Bonkovsky. Herbert L. Bonkovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghabril, Marwan, et al.. (2024). Su1525 LIVER INJURY FROM MEDICATIONS USED FOR TREATING INFLAMMATORY BOWEL DISEASE: THE DRUG-INDUCED LIVER INJURY NETWORK EXPERIENCE. Gastroenterology. 166(5). S–770.

Bonkovsky, Herbert L., et al.. (2023). Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive Diseases and Sciences. 68(6). 2738–2746. 4 indexed citations

Kuter, David J., Herbert L. Bonkovsky, Gayle Ross, et al.. (2023). Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. Journal of Hepatology. 79(5). 1150–1158. 27 indexed citations

Levy, Cynthia, Karl E. Anderson, Manisha Balwani, et al.. (2023). PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA. HemaSphere. 7(S3). e904346e–e904346e. 1 indexed citations

Chalasani, Naga, Yi‐Ju Li, Andrew Dellinger, et al.. (2022). Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury. Journal of Hepatology. 78(2). 293–300. 25 indexed citations

Cassiman, David, Raili Kauppinen, Ming‐Jen Lee, et al.. (2022). EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms. Journal of Inherited Metabolic Disease. 45(6). 1163–1174. 14 indexed citations

Anderson, Karl E., Robert J. Desnick, M F Stewart, Paolo Ventura, & Herbert L. Bonkovsky. (2021). Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features That Should Prompt Specific Diagnostic Testing. The American Journal of the Medical Sciences. 363(1). 1–10. 6 indexed citations

Stein, Penelope E., D. Rees, Karl E. Anderson, et al.. (2020). A phase 1/2 open label extension study of givosiran, an investigational RNAi therapeutic, in patients with acute intermittent porphyria. Journal of Hepatology. 73. S553–S554. 9 indexed citations

Dickey, Amy K., Corbin Quick, Sarah Ducamp, et al.. (2020). Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria. Genetics in Medicine. 23(1). 140–148. 22 indexed citations

10.

Bossi, Krista, Jingyun Lee, Paul A. Schmeltzer, et al.. (2015). Homeostasis of iron and hepcidin in erythropoietic protoporphyria. European Journal of Clinical Investigation. 45(10). 1032–1041. 21 indexed citations

11.

Navarro, Victor J., Huiman X. Barnhart, Herbert L. Bonkovsky, et al.. (2014). Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 60(4). 1399–1408. 292 indexed citations breakdown →

12.

Bonkovsky, Herbert L., Vinaya C. Maddukuri, Cemal Yazıcı, et al.. (2014). Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium. The American Journal of Medicine. 127(12). 1233–1241. 173 indexed citations

13.

Phatak, Pradyumna D., Pierre Brissot, Paul C. Adams, et al.. (2010). A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary Hemochromatosis. Hepatology. 52(5). 1671–1779. 87 indexed citations

14.

Shiffman, Mitchell L., Chihiro Morishima, Jules L. Dienstag, et al.. (2009). Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial. Gastroenterology. 137(6). 1986–1994. 30 indexed citations

15.

Venkataraman, Krishnan, Yong-Moon Lee, Jason Michaud, et al.. (2008). Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate. Circulation Research. 102(6). 669–676. 391 indexed citations

16.

Lok, Anna S., Leonard B. Seeff, Timothy R. Morgan, et al.. (2008). Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease. Gastroenterology. 136(1). 138–148. 452 indexed citations

17.

Chalasani, Naga, Robert J. Fontana, Paul B. Watkins, et al.. (2006). Drug Induced Liver Injury Network (DILIN) Prospective Study. The American Journal of Gastroenterology. 101. S169–S169. 8 indexed citations

18.

Shan, Ying, R Lambrecht, & Herbert L. Bonkovsky. (2005). Association of Hepatitis C Virus Infection with Serum Iron Status: Analysis of Data from the Third National Health and Nutrition Examination Survey. Clinical Infectious Diseases. 40(6). 834–841. 49 indexed citations

19.

Bonkovsky, Herbert L.. (1987). Porphyria: Practical Advice for the Clinical Gastroenterologist and Hepatologist. Digestive Diseases. 5(3). 179–192. 4 indexed citations

20.

Bonkovsky, Herbert L., et al.. (1985). Cytochrome P450 of small intestinal epithelial cells. Gastroenterology. 88(2). 458–467. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact